Portage Biotech Inc
PRTG
Market Cap$4.82M
Close$
$0.65
125.6% upside
Current Fair Value
125.6% upsideUndervalued by 125.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.82 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $0.0 |
| Beta | 2.17 |
| Outstanding Shares | 17,801,391 |
| Avg 30 Day Volume | 153,152 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0.0 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
ESG Score
No data
About Portage Biotech Inc
Portage Biotech Inc. is a unique entity in the world of biotechnology, catalyzing R&D to produce more quality clinical programs and maximize potential returns.